KLK3 and prostate carcinoma: On the other hand, protein biomarkers detectable in blood or other body fluids, in addition to those detected in tumors, also include tissue/cell-specific proteins that have increased levels in body fluids compared to normal, e.g., PSA in the plasma of prostate cancer patients.